4//SEC Filing
SUVRETTA CAPITAL MANAGEMENT, LLC 4
Accession 0000899140-25-000479
CIK 0001808898other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:51 PM ET
Size
27.8 KB
Accession
0000899140-25-000479
Insider Transaction Report
Form 4
SUVRETTA CAPITAL MANAGEMENT, LLC
Director10% Owner
Transactions
- Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+106,200$1,380,600→ 1,066,764 total(indirect: See footnotes) - Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+793,800$10,319,400→ 8,793,245 total(indirect: See footnotes)
Averill Madison Master Fund, Ltd.
Director10% Owner
Transactions
- Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+793,800$10,319,400→ 8,793,245 total(indirect: See footnotes) - Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+106,200$1,380,600→ 1,066,764 total(indirect: See footnotes)
Averill Master Fund, Ltd.
Director10% Owner
Transactions
- Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+793,800$10,319,400→ 8,793,245 total(indirect: See footnotes) - Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+106,200$1,380,600→ 1,066,764 total(indirect: See footnotes)
Cowen Aaron
10% Owner
Transactions
- Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+106,200$1,380,600→ 1,066,764 total(indirect: See footnotes) - Purchase
Common stock, par value $0.0001 per share
2025-03-26$13.00/sh+793,800$10,319,400→ 8,793,245 total(indirect: See footnotes)
Footnotes (3)
- [F1]Notes are included on Exhibit 99.1.
- [F2]Notes are included on Exhibit 99.1.
- [F3]Notes are included on Exhibit 99.1.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001569064
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:51 PM ET
- Size
- 27.8 KB